11-15 11-16 11-17
2024-11-15(Friday)08:30-13:00
展开
L1, Pearl Hall
Youth Forum
08:30-10:05

第一节 [Youth Forum]

08:30-08:35

Opening

08:35-08:55

Proteome-Centric Multi-Omics Approach for Identifying Therapeutic Targets in Acute Myeloid Leukemia

王洪

中国医学科学院血液病医院

Hong Wang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
08:55-09:15

Targeting Cell Death to Augment Cancer Immunotherapy

潘荣清

浙江大学

Rongqing Pan

Zhejiang University
09:15-09:35

The Role and Clinical Application of NK Cells in Pregnancy Complication

傅斌清

中国科学技术大学

Binqing Fu

University of Science and Technology of China
09:35-09:55

Clonal Hematopoiesis of Indeterminate Potential Links Periodontitis and Inflammatory Comorbidities

王辉

四川大学

Hui Wang

Sichuan University
09:55-10:05

Coffee Break

10:05-13:00

第二节 [Youth Forum]

10:05-10:25

Single-cell Pan-leukemia Signatures of HSPC-like Blasts Predict Drug Response and Clinical Outcome

陈昌亚

中国医学科学院血液病医院

Changya Chen

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
10:25-10:45

Production of Human Enucleated RBCs ex vivo: Mechanisms and Applications

刘森泉

中国科学技术大学

Senquan Liu

University of Science and Technology of China
10:45-11:05

Design and Functional Study of Synthetic Cytokines

任俊明

浙江大学

Junming Ren

Zhejiang University
11:05-11:25

The Heterogeneity and Regulatory Mechanisms of T cells in Autoimmune Diseases

陈坤

同济大学

Kun Chen

Tongji University
11:25-11:45

Precise Regulation of Type I Interferon Signaling in T.gondii-mediated Cancer Immunotherapy

余潇

南方医科大学

Xiao Yu

Southern Medical University
12:00-13:00

Lunch

2024-11-15(Friday)08:30-13:00
展开
L3, Diamond Ballroom 4+5
Industrial Development Forum 产业发展论坛 (中文)
08:30-10:40

第一节 [Industrial Development Forum 产业发展论坛 (中文)]

08:30-08:50

Opening and guest speech 开幕致辞

08:50-09:00

Exhibition Opening Ceremony 展商剪彩仪式

09:00-09:20

基于监管探讨细胞制剂的质量控制

梁锦锋

浙江省药品化妆品审评中心

Jinfeng Liang

Zhejiang Provincial Center for Drug and Cosmetic Evaluation
09:20-09:40

细胞和基因治疗临床研究的规范管理和申请流程

赵青威

浙江大学

Qingwei Zhao

Zhejiang University
09:40-10:00

MRD阴性率作为MM研究主要终点探讨

陈杰

南京驯鹿生物医药有限公司

Jie Chen

Nanjing lASO Medical Technology Co.. Ltd.
10:00-10:20

Next Generation CAR-T Technologies for Hematopoietic Malignancies.

何晓文

原启生物科技(上海)有限责任公司

Xiaowen He

Yuanqi Biotechnology (Shanghai) Co., Ltd
10:20-10:40

Coffee Break:

10:40-13:00

第二节 [Industrial Development Forum 产业发展论坛 (中文)]

11:00-11:20

CAR-T 市场的先行者和破局者 Pioneer and lcebreaker in China CAR-T market

陈星蓉

复星凯特(上海)生物科技有限公司

Xingrong Chen

Shanghai Fosun Kairos Biotechnology Co., Ltd
11:20-11:40

Off-the-shelf Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

郑彪

上海邦耀生物科技有限公司

Biao Zheng

Shanghai Bangyao Biotechnology Co., Ltd
11:40-12:00

通用型 CAR-T 细胞的开发与展望

任江涛

南京北恒生物科技有限公司

Jiangtao Ren

Nanjing Beiheng Biotechnology Co., Ltd
12:00-13:00

Lunch:

2024-11-15(Friday)12:00-13:00
展开
2F Conference room 2
12:00-13:00

lACH Committee Meeting (By Invitation)

2024-11-15(Friday)13:30-17:30
展开
L1,Crystal Ballroom
Main venue A Plenary session I: Clinical & Translational Research
13:30-14:00

[Plenary session I: Clinical & Translational Research]

Opening ceremony [Main venue A Plenary session I: Clinical & Translational Research]

14:00-16:00

第一节 [Plenary session I: Clinical & Translational Research]

14:00-14:30

Progress in the therapy of GVHD

Mohamad Mohty

Saint-Antoine Hospital and Sorbonne University

Mohamad Mohty

Saint-Antoine Hospital and Sorbonne University
14:30-15:00

Novel Cellular Therapy for Hematological Malignant Diseases

黄河

浙江大学

He Huang

Zhejiang University
15:00-15:30

Points to Consider for Cellular Therapy

15:30-16:00

Coffee Break

16:00-17:30

第二节 [Plenary session I: Clinical & Translational Research]

16:00-16:30

Type 2 Immunity May Hold Key to Long-term Cancer Remission

唐力

Swiss federal Institute of Technology in Lausanne,Switzerland

Li Tang

Swiss federal Institute of Technology in Lausanne,Switzerland
16:30-17:00

Integration of CAR-T into Total Therapy of Acute Lymphoblastic Leukemia

王建祥

中国医学科学院血液病医院

Jianxiang Wang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
17:00-17:30

Allogenic CAR-T Cell Therapy for Autoimmune Diseases

徐沪济

海军军医大学

Huji Xu

Naval Medical University
2024-11-15(Friday)13:00-17:30
展开
L3,Diamond Ballroom 4+5
Main venue B Plenary session II: Advances in Immune Cell Therapy
13:00-13:20

[Plenary session II: Advances in Immune Cell Therapy]

Opening ceremony [Main venue B Plenary session II: Advances in Immune Cell Therapy]

13:25-15:40

第一节 [Plenary session II: Advances in Immune Cell Therapy]

13:25-14:00

Myeloid-mediated Mechanisms of Resistance to Cancer Immunotherapy

Lawrence Fong

Fred Hutchinson Cancer Center, USA

Lawrence Fong

Fred Hutchinson Cancer Center, USA
14:00-14:35

Cell Injury and Tissue Homeostasis in Inflammatory Bowel Disease

陈家明

浙江大学

Jiaming Chen

Zhejiang University
14:35-15:00

Developing TCR-based Chimeric Antigen Receptor for Immunotherapy

林欣

清华大学

Xin Lin

Tsinghua University
15:00-15:25

Gene Editing and Innovative CAR-T Therapy in Cancer and Autoimmune Diseases

刘明耀

华东师范大学

Mingyao Liu

East China Normal University
15:25-15:40

Coffee Break

15:40-17:30

第二节 [Plenary session II: Advances in Immune Cell Therapy]

15:40-16:15

Harnessing Charge-mediated Immunoreceptor Signaling in T Cell Therapy

许琛琦

中国科学院分子细胞科学卓越创新中心

Chenqi Xu

Center for Excellence in Molecular Cell Science, CAS
16:15-16:40

CD7 CAR-T Bridged to allo-HSCT: Novel Strategies and Corresponding Mechanisms

胡永仙

浙江大学

Yongxian Hu

Zhejiang University
16:40-17:05

CAR-T Rational Design Driven by Artificial Intelligence

王皞鹏

上海科技大学

Haopeng Wang

ShanghaiTech University
17:05-17:30

Human T-cell Development and Aging

胡洪波

四川大学

Hongbo Hu

Sichuan University
2024-11-15(Friday)19:00-20:30
展开
L1,Crystal Ballroom
19:00-20:30

Welcome reception(L1,Crystal Ballroom/水晶宫)